HUP0400262A3 - Glycopeptides, their preparation and use in the treatment of multiple sclerosis - Google Patents

Glycopeptides, their preparation and use in the treatment of multiple sclerosis

Info

Publication number
HUP0400262A3
HUP0400262A3 HU0400262A HUP0400262A HUP0400262A3 HU P0400262 A3 HUP0400262 A3 HU P0400262A3 HU 0400262 A HU0400262 A HU 0400262A HU P0400262 A HUP0400262 A HU P0400262A HU P0400262 A3 HUP0400262 A3 HU P0400262A3
Authority
HU
Hungary
Prior art keywords
glycopeptides
preparation
treatment
multiple sclerosis
sclerosis
Prior art date
Application number
HU0400262A
Other languages
English (en)
Original Assignee
Univ Firenze
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11442221&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0400262(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Firenze filed Critical Univ Firenze
Publication of HUP0400262A2 publication Critical patent/HUP0400262A2/hu
Publication of HUP0400262A3 publication Critical patent/HUP0400262A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
HU0400262A 2001-06-22 2002-06-19 Glycopeptides, their preparation and use in the treatment of multiple sclerosis HUP0400262A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001FI000114A ITFI20010114A1 (it) 2001-06-22 2001-06-22 Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
PCT/EP2002/006767 WO2003000733A2 (en) 2001-06-22 2002-06-19 Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis

Publications (2)

Publication Number Publication Date
HUP0400262A2 HUP0400262A2 (hu) 2004-08-30
HUP0400262A3 true HUP0400262A3 (en) 2008-05-28

Family

ID=11442221

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0400262A HUP0400262A3 (en) 2001-06-22 2002-06-19 Glycopeptides, their preparation and use in the treatment of multiple sclerosis

Country Status (15)

Country Link
US (1) US7037893B2 (hu)
EP (1) EP1406927B1 (hu)
AT (1) ATE393785T1 (hu)
AU (1) AU2002316989B2 (hu)
CA (1) CA2451347C (hu)
CZ (1) CZ2004122A3 (hu)
DE (1) DE60226324T2 (hu)
DK (1) DK1406927T3 (hu)
ES (1) ES2305258T3 (hu)
HU (1) HUP0400262A3 (hu)
IL (2) IL159479A0 (hu)
IT (1) ITFI20010114A1 (hu)
PL (1) PL207174B1 (hu)
PT (1) PT1406927E (hu)
WO (1) WO2003000733A2 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
ITFI20010144A1 (it) * 2001-07-25 2003-01-25 Univ Firenze Colonne per immunoassorbimento per sottrazione di autoanticorpi dal sangue con tecniche di plasmafiltrazione selettiva
WO2004015420A1 (en) * 2002-08-02 2004-02-19 Glycominds Ltd. Method for diagnosing multiple sclerosis
US7572592B2 (en) 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
US8216791B2 (en) 2005-01-31 2012-07-10 Glycominds Ltd. Method for diagnosing multiple sclerosis
US20080267988A1 (en) * 2007-04-11 2008-10-30 Enteron Limited Partnership Myelin specific IgE unencumbered by corresponding blocking antibodies as a causative factor in multiple sclerosis
CA2683865A1 (en) 2007-04-12 2008-10-23 Apitope International Nv Biomarkers for multiple sclerosis
ATE514711T1 (de) 2007-10-16 2011-07-15 Toscana Biomarkers S R L Galactosylierte peptide, deren zubereitung und verwendung zur diagnose von autoimmunerkrankungen
US20100203569A1 (en) 2009-02-12 2010-08-12 Glycominks LTD Method for Evaluating Risk in Multiple Sclerosis
ITFI20120164A1 (it) 2012-06-05 2013-12-06 Azienda Ospedaliera Universitaria S Enese 50 Nuovi peptidi glicosilati.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997035879A1 (en) 1996-03-28 1997-10-02 Immulogic Pharmaceutical Corporation Myelin oligodendrocyte glycoprotein peptides and uses thereof
EP1080185A4 (en) 1998-05-05 2005-01-26 Corixa Corp BASIC PROTEIN PEPTIDES OF MYELIN AND THE USE THEREOF.
US6333033B1 (en) 1998-08-26 2001-12-25 The Regents Of The University Of California Autoantibody inhibitors
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
ITRM20010408A1 (it) * 2001-07-10 2003-01-10 Univ Napoli Federico Ii Mini-anticorpo umano citotossico per cellule tumorali che esprimono il recettore erbb2.

Also Published As

Publication number Publication date
EP1406927B1 (en) 2008-04-30
AU2002316989B2 (en) 2006-10-26
HUP0400262A2 (hu) 2004-08-30
IL159479A (en) 2010-12-30
PL368158A1 (en) 2005-03-21
US7037893B2 (en) 2006-05-02
WO2003000733A2 (en) 2003-01-03
PT1406927E (pt) 2008-07-31
US20040235713A1 (en) 2004-11-25
WO2003000733A3 (en) 2003-11-13
CA2451347C (en) 2011-07-19
EP1406927A2 (en) 2004-04-14
PL207174B1 (pl) 2010-11-30
IL159479A0 (en) 2004-06-01
ITFI20010114A1 (it) 2002-12-22
CZ2004122A3 (cs) 2004-07-14
CA2451347A1 (en) 2003-01-03
DE60226324T2 (de) 2009-07-09
ATE393785T1 (de) 2008-05-15
DE60226324D1 (de) 2008-06-12
DK1406927T3 (da) 2008-08-18
ES2305258T3 (es) 2008-11-01

Similar Documents

Publication Publication Date Title
PT1757606E (pt) Utilização de derivados de xantina como produto farmacêutico, bem como seu processo de preparação
HUP0402113A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, preparation and use thereof
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
IL219671A0 (en) 1,2- benzoxazoles and use thereof in the preparation of a medicament
IL159015A0 (en) Polypeptides, their preparation and use
HK1078266A1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
HK1056877A1 (en) Mch antagonists and their use in the treatment of obesity.
HK1109160A1 (en) Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
HK1068555A1 (en) New formulations and use thereof
AU2002308348A1 (en) Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
HUP0400069A3 (en) Pharmaceutical combinations and their use in preventing and treating the thrombosis
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
GB0108470D0 (en) Pharmaceutical compositions and their use
EP1578769A4 (en) PEPTIDES AND THEIR USE TO DARK THE SKIN
IL158397A0 (en) Polypeptides, their preparation and their use
GB0121148D0 (en) Polymers and their use
SI1462455T1 (sl) Ser-Ser-Ser-Arg Peptid in zdravilna uporaba le-tega
HUP0400262A3 (en) Glycopeptides, their preparation and use in the treatment of multiple sclerosis
AU2002243363A1 (en) Use of aziridino-compounds in the treatment of immune dysfunctions
GB0119025D0 (en) Compounds and their therapeutic use
EP1367123A4 (en) NEUROTONIN AND ITS USE
GB0200843D0 (en) Benzodioxinopyrroles their preparation and use
GB2376943B (en) Compounds and their therapeutic use
GB0112237D0 (en) Compounds and their therapeutic use

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees